PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880641
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880641
The global pressure/contact-activated safety lancet market is witnessing significant growth due to the increasing prevalence of diabetes, rising demand for minimally invasive blood sampling, and the shift toward home-based diagnostics. The market was valued at USD 414.9 million in 2024, is projected to reach USD 456.2 million in 2025, and is expected to expand to USD 933.0 million by 2032, representing a CAGR of 10.8% during the forecast period. North America dominated the global market in 2024 with a 42.35% share, driven by advanced healthcare infrastructure, high awareness, and extensive adoption of safe and easy-to-use lancets.
Pressure/contact-activated safety lancets are single-use, disposable devices designed for capillary blood sampling, particularly for diabetes management and other diagnostic applications. These devices feature automatic retraction, are activated by applying small pressure on the fingertip, and eliminate the need for manual triggering. The lancets provide reduced pain, minimal blood loss, and improved hygiene, making them highly suitable for home and clinical use.
Market Drivers
The primary driver of this market is the rising prevalence of diabetes worldwide. According to the International Diabetes Federation, around 589 million adults were living with diabetes globally in 2024, projected to increase to 853 million by 2050. Frequent self-monitoring of blood glucose (SMBG) drives demand for user-friendly lancets, as pressure/contact-activated devices ensure consistent penetration depth, reduce needlestick injuries, and simplify daily monitoring.
Another significant growth driver is the shift toward home healthcare monitoring. With rising chronic disease prevalence, patients prefer cost-effective, convenient self-monitoring solutions. Contact-activated lancets, which eliminate the need for button activation, are ideal for untrained users, including elderly and pediatric patients, facilitating home diagnostics and boosting market adoption.
Market Restraints
The growth of pressure/contact-activated lancets faces competition from button-activated safety lancets, which provide predictable penetration depth, ergonomic designs, and multi-depth adjustments. Button-activated models are increasingly preferred in clinical and home settings, limiting the adoption of pressure-activated devices. Additionally, limited accessibility in low- and middle-income countries, coupled with affordability challenges and inadequate healthcare infrastructure, restrains market growth, particularly in regions such as South Asia and parts of Africa.
Market Opportunities
Technological advancements, such as ultra-fine gauge needles (21G-30G) and spring-loaded mechanisms, offer nearly painless blood sampling and patient comfort. The growing adoption of minimally invasive, ergonomic designs and the shift toward home-based self-monitoring provide significant market opportunities. Rising awareness of safe blood sampling practices in emerging economies further enhances the potential for growth.
Competitive Landscape
Key players dominating the global market include BD, Cardinal Health, HTL-STREFA (MTD Medical Technology and Devices), Medline Industries, Owen Mumford, and Braun SE. Companies are focusing on product innovation, strategic collaborations, and geographic expansion to enhance market reach. For example, in January 2025, BD expanded its U.S. manufacturing network to meet growing demand, while Sterilance Medical showcased its latest products at MEDICA 2024.
In conclusion, the pressure/contact-activated safety lancet market is set to expand from USD 414.9 million in 2024 to USD 933.0 million by 2032, driven by rising diabetes prevalence, technological innovations, and the increasing trend toward home healthcare monitoring. As patient-friendly, minimally invasive, and safer lancet designs gain prominence, this market is poised for sustained growth globally.
Segmentation By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Region
By Incision Type * Needle
By Age Group * Adult
By Application * Blood Glucose Monitoring
By Gauge Size * 22G and Below
By Distribution Channel * Hospital Pharmacies
By Region * North America (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Country)
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Brazil
Mexico
Rest of Latin America
GCC
South Africa
Rest of the Middle East & Africa